Blood pressure rise in early morning is considered an important risk factor for vascular complications of hypertension. We examined the characteristics of hypertensive patients who have a blood pressure rise in the morning judged by self-measurement of blood pressure at home concerning to the hypertensive cardiovascular complications. The subjects enrolled in this study were 218 untreated hypertensive patients (132 men and 86 women, mean age; 55.2Ϯ11.2 years). Subjects were instructed by nursing stuffs how to measure their own blood pressures at home. Monitor used in this study was cuff-oscillometric device (Omron HEM-737, Omron, Tokyo), which was checked by connecting to the sphygmomanometer with a Y-connector at monthly clinic visits. Subjects were asked to measure their home blood pressure in the morning within 30 min after awakening and in the evening just before going to bed. Subjects were divided to two groups according to the difference of systolic blood pressure (SBP) between morning and evening (M-SBP-E-SBP); morning rise group (MR) ϭ M-SBP-E-SBP Ն10 mmHg (nϭ61) and non-morning rise group (NMR) ϭ M-SBP-E-SBPϽϮ10 mmHg (nϭ157). Two-dimension guided M-mode echocardiograms of left ventricle were recorded. End-systolic and end-diastolic measurements of left ventricular internal dimension, interventricular septal thickness, and left ventricular posterior wall thickness were made according to the American Society of Echocardiography recommendations. Left ventricular mass index was calculated using the formula introduced by Devereux et al. End-diastolic relative wall thickness was calculated as the ratio of posterior wall thickness to one-half left ventricular internal dimension. MR group was more common in men (36.4% vs 15.1%, pϭ0.001). MR subjects had increased end-diastolic relative wall thickness (0.453Ϯ0.066 vs 0.428Ϯ0.059, pϭ0.008), left ventricular mass index (130Ϯ25 vs 100Ϯ15 g/m 2 , pϽ0.001), serum creatinine (Cr, 0.78Ϯ0.18 vs 0.73Ϯ0.16 mg/dl, pϭ0.027) and urinary protein excretion (100Ϯ165 vs 34Ϯ48 mg/g Cr, pϭ0.007) compared to NMR ones. It can be concluded that the hypertensive patients with a morning rise in blood pressure have advanced hypertensive cardiovascular complications.
Our knowledge about precise function of beta 3 receptor (␤ 3 R) in the mammalian heart in vivo is poorly characterized. The present study aimed to investigate the role of ␤ 3 R in cardiac hypertrophy. Combined ␤ 1 or ␤ 2 antagonist metoprolol (0.5mg/kg/h), the ␤ 3 R agonist BRL37344 (30mg/kg/h), or both, or vehicle were infused via subcutaneously implanted osmotic mini pumps in 44 male SD-rats for 72 hours. Left ventricular weight/body weight (LV/BW) ratio was elevated in BRL37344 and BRL37344 ϩ metoprolol treated groups. (10.3Ϯ0.9% (pϽ0,01); and 9,5Ϯ0.8% (pϽ0,05) vs. sham respectively). We measured the gene expression of substances whith antihypertrophic or antifibrotic effect, like: atrial natriuretic peptide (ANP), B-type natriuretic peptide (BNP), and the embryonic contractile protein skeletal ␣-actin mRNA levels, in the left ventricles by Northern-blotting. BRL37344 elevated ANP expression with 64Ϯ18.9% meanwhile the combined therapy increased it with 55Ϯ19,6%, (pϽ0,01) vs. sham), BNP gene expression elevated 74Ϯ23.2% (pϽ0,01) and 123Ϯ24.9% vs. sham respectively). None of the above mentioned therapy affect the gene expression of skeletal ␣-actin at 72 hours. The investigated parameters (LV/BW, ANP, BNP and skeletal ␣-actin mRNA) did not differ between the BRL37344 or BRL37344 ϩ metoprolol treated group. We conclude that BRL37344 infusion rapidly increased left ventricular mass, and induced the expression of representative genes in cardiac remodeling or hypertrophy. We conclude that BRL37344 treatment in vivo induce left ventricular hypertrophy which is the result of the selective stimulation ␤ 3 R. The aim was to study the echocardiographic changes in patients with malignant phase hypertension (MHT). We studied 17 consecutive patients (12 male; mean age 50Ϯ 13 years) with MHT who were admitted to the City Hospital Birmingham. Routine trans-thoracic echocardiography was carried out in these patients, and measurements were compared to those of 22 patients (19 male; mean age 56 Ϯ 12 years) with controlled hypertension, and 20 (12 male; mean age 53 Ϯ9 years) healthy normotensive volunteers.
We found that the patients with MHT had a significantly higher systolic and diastolic blood pressure (pϽ0.001) as compared to the other two groups. MHT patients had a larger left atrium (pϭ0.002) and larger aortic root (pϭ0.01), thicker posterior walls (pϭ0.002)and interventricular septum(pϽ0.001) as well as a larger Left ventricular Mass and LV Mass Index (pϭ0.001) as compared to the other two groups. The MHT patients had a significantly lower ejection fraction (pϽ0.001).
We conclude that patients with MHT have significantly hypertrophied left ventricules in association with systolic dysfunction and enlarged left atria. These findings may predispose MHT patients to cardiovascular complications including arrhythmias such as atrial fibrillation.
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